139 related articles for article (PubMed ID: 25572158)
1. Sulfamethoxazole-trimethoprim associated with resveratrol for the treatment of toxoplasmosis in mice: Influence on the activity of enzymes involved in brain neurotransmission.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Nishihira VS; Thomé GR; Schetinger MR; Morsch VM; Camillo G; Vogel FF; Tochetto C; Fighera R; Machado G; Stefani LM; Da Silva AS
Microb Pathog; 2015 Feb; 79():17-23. PubMed ID: 25572158
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Alves CB; D'Avila F; Thomé GR; Guarda NS; Moresco RN; Camillo G; Vogel FF; Luchese C; Schetinger MRC; Morsch VM; Tochetto C; Fighera R; Nishihira VSK; Da Silva AS
Microb Pathog; 2016 Jun; 95():166-174. PubMed ID: 27057672
[TBL] [Abstract][Full Text] [Related]
3. Effects of sulfamethoxazole-trimethoprim associated to resveratrol on its free form and complexed with 2-hydroxypropyl-β-cyclodextrin on cytokines levels of mice infected by Toxoplasma gondii.
Bottari NB; Baldissera MD; Tonin AA; Rech VC; Nishihira VS; Thomé GR; Camillo G; Vogel FF; Duarte MM; Schetinger MR; Morsch VM; Tochetto C; Fighera R; Da Silva AS
Microb Pathog; 2015 Oct; 87():40-4. PubMed ID: 26209515
[TBL] [Abstract][Full Text] [Related]
4. Diphenyl diselenide supplementation in infected mice by Toxoplasma gondii: Protective effect on behavior, neuromodulation and oxidative stress caused by disease.
Machado VS; Bottari NB; Baldissera MD; Rech VC; Ianiski FR; Signor C; Rubin MA; Waczuk EP; Schwertz CI; Mendes RE; Camillo G; Vogel FF; de la Rue ML; Morsch VM; Schetinger MR; Frühauf PK; Da Silva AS
Exp Parasitol; 2016 Oct; 169():51-8. PubMed ID: 27472985
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: Effects of diphenyl diselenide in experimental toxoplasmosis on biomarkers of cardiac function.
Machado VS; Bottari NB; Baldissera MD; Isabel de Azevedo M; Rech VC; Ianiski FR; Vaucher RA; Mendes RE; Camillo G; Vogel FF; de la Rue ML; Carmo GM; Tonin AA; Da Silva AS
Exp Parasitol; 2016 Aug; 167():25-31. PubMed ID: 27107930
[TBL] [Abstract][Full Text] [Related]
6. Influence of toxoplasmosis on acetylcholinesterase activity, nitric oxide levels and cellular lesion on the brain of mice.
Tonin AA; Da Silva AS; Thomé GR; Sangoi MB; Oliveira LS; Flores MM; Schetinger MR; Fighera RA; Moresco RN; Camillo G; Vogel FS; Lopes ST
Pathol Res Pract; 2014 Aug; 210(8):526-32. PubMed ID: 24951243
[TBL] [Abstract][Full Text] [Related]
7. Hepatic xanthine oxidase activity and purine nucleosides levels as physiological mediators to analyze a subcutaneous treatment with (PhSe)
Doleski PH; Leal DB; Machado VS; Bottari NB; Casali EA; Moritz CE; Camillo G; Vogel FF; Stefani LM; da Silva AS
Microb Pathog; 2017 Mar; 104():180-183. PubMed ID: 28089947
[TBL] [Abstract][Full Text] [Related]
8. Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii.
Da Silva AS; Tonin AA; Thorstenberg ML; Leal DB; Fighera R; Flores MM; França RT; Camillo G; Vogel FS; de la Rue M; Lopes ST
Pathol Res Pract; 2013 Feb; 209(2):95-8. PubMed ID: 23313104
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[
